Thoracoscopic lobectomy
Conditions
Interventions
Control group:Sufentanil combined with ketorolac ambutritol
Experimental group1:Low dose of butorphanol tartrate combined with ketorolol tritriol
Experimental group2:Medium dose of butorphanol tartrate combined with ketorolol tritriol
Experimental group3:High dose of butorphanol tartrate combined with ketorolol tritriol
Sponsors
The First Affiliated Hospital of DaLian Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 65 years, gender is not limited; 2. Patients who received conventional thoracoscopic radical resection of lung cancer; 3. ASA classification I or II; 4. 18kg/m^2 < BMI < 30kg/m^2; 5. Clearly understand and voluntarily participate in the research, and sign the informed consent form by myself.
Exclusion criteria
Exclusion criteria: 1. Long-term history of taking sedative and analgesic drugs; 2. Have a history of gastrointestinal ulcers and blood system diseases; 3. Liver, kidney and coagulation dysfunction; 4. Intelligence, language disorder, schizophrenia, severe depression.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| untoward effect;40-item Recovery Quality Scale Score;Ramsay sedation score;Changes of Th17/Treg levels at different time points in peripheral blood; | — |
Countries
China
Contacts
Public ContactWen Qingping
The First Affiliated Hospital of Dalian Medical University
Outcome results
None listed